NOCIL Ltd
NOCIL Q2 Results 2026 (FY27): Capex ₹130 Cr
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #55 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
NOCIL Ltd Q2 FY27 key numbers
- Revenue
- Quarterly Revenue (Q2FY27): Rs. 427 crores.
As stated in NOCIL Ltd's Q2 FY27 investor presentation · published 29 Oct 2026. Reported figures, not investment advice.
Based on NOCIL Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Quarterly Revenue (Q2FY27): Rs. Quarterly EBITDA (Q2FY27): ₹36 crores - Year-on-year (YoY) increase: 61% (from ₹22 crores in Q2FY26) - Operating EBITDA Margin (Q2FY27): 8.4% - YoY margin (Q2FY26): 7.0% - Net Prof
From NOCIL Ltd's Q2 FY27 earnings-call transcript · updated 29 Oct 2026.
Revenue & Sales Performance
- Quarterly Revenue (Q2FY27): Rs. 427 crores
- Year-on-Year (Y-o-Y) Revenue Growth: 33% (Q2FY27 vs. Q2FY26)
- Quarterly Volume (Q2FY27): 427 units (base 100)
- Y-o-Y Volume Change: Declined by 3% (Q2FY27 vs. Q2FY26)
- Q-o-Q Volume Change: Declined by 7% (Q2FY27 vs. Q1FY27)
2 more points from NOCIL Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what NOCIL Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Dahej Plant Expansion:
- ₹250 Crore brownfield expansion, completed ahead of schedule and within budget.
- Moved into trial production and samples sent for approval.
- Navi Mumbai Plant Expansion:
- Announced a ₹130 Crore brownfield capex program in March 2026.
- Purpose: Expand capacity for peak-utilization rubber chemical products, including backward integration of inputs.
- Targeted completion: H1 FY28.
- Funding: Largely through internal accruals.
- Integrated Speciality Rubber Chemicals Project:
2 more points from NOCIL Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what NOCIL Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what NOCIL Ltd said on order book & pipeline — free account, 30 seconds.
NOCIL Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹427 Cr, net profit ₹24 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What NOCIL Ltd's management said in earlier quarters
- Q4 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
- Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
- Neochem Bio Solutions Ltd (Q2 FY27)
Revenue from Operations for H1 FY27: ₹68.9 crores, up 50% YoY (from ₹45.8 crores in H1 FY26) [Page 22] . Key investor presentation takeaways from Neochem Bio So
- Sadhana Nitro (Q2 FY27)
EBITDA for the quarter ended September 30, 2026: ₹1,051 lakh, a 21% year-on-year (YoY) increase. Key results statement takeaways from Sadhana Nitro Chem Ltd's Q
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
NOCIL Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were NOCIL Ltd Q2 FY27 results?
Quarterly Revenue (Q2FY27): Rs. Quarterly EBITDA (Q2FY27): ₹36 crores - Year-on-year (YoY) increase: 61% (from ₹22 crores in Q2FY26) - Operating EBITDA Margin (Q2FY27): 8.4% - YoY margin (Q2FY26): 7.0% - Net Prof
What is NOCIL Ltd share price analysis?
NOCIL Ltd currently shows a neutral. The stock trades at a P/E of 35.2 with a market cap of ₹2,447 Cr. Investors should review the full earnings analysis for detailed insights.
Is NOCIL Ltd planning capital expenditure?
Dahej Plant Expansion: - ₹250 Crore brownfield expansion, completed ahead of schedule and within budget.
Keep NOCIL Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.